CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-06 | Mayo Stephen Director | Grant or award | +1,523 | 7,910 | ||
| 2023-03-06 | Mayo Stephen Director | Grant or award · Stock Option (right to buy) | +3,257 | 3,257 | ||
| 2023-03-01 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −80 | $147.57 | $12K | 22,837 |
| 2023-03-01 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −172 | $147.57 | $25K | 22,828 |
| 2023-03-01 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −196 | $147.57 | $29K | 25,645 |
| 2023-03-01 | Estepan Ian Michael Chief Financial Officer | Shares withheld for taxes | −378 | $147.57 | $56K | 32,293 |
| 2023-03-01 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −522 | $147.57 | $77K | 67,716 |
| 2022-12-31 | Arif Bilal Chief Tech Ops Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-12-19 | BEHRENS M KATHLEEN Director | Exercise or conversion | +20,000 | $34.92 | $698K | 158,470 |
| 2022-12-19 | BEHRENS M KATHLEEN Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2022-11-17 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −4,211 | $108.52 | $457K | 67,998 |
| 2022-11-17 | Mayo Stephen Director | Sale | −858 | $109.92 | $94K | 6,387 |
| 2022-09-14 | Chambers Michael Andrew Director | Purchase | +20,744 | $103.87 | $2.2M | 71,822 |
| 2022-09-14 | Chambers Michael Andrew Director | Purchase | +30,106 | $104.67 | $3.2M | 101,928 |
| 2022-09-14 | Chambers Michael Andrew Director | Purchase | +6,250 | $105.16 | $657K | 108,178 |
| 2022-09-13 | Chambers Michael Andrew Director | Grant or award · Convertible Senior Notes | +0 | $20,000,000.00 | $0 | |
| 2022-08-19 | Chambers Michael Andrew Director | Purchase | +40,110 | $108.20 | $4.3M | 45,018 |
| 2022-08-19 | Chambers Michael Andrew Director | Purchase | +6,060 | $108.80 | $659K | 51,078 |
| 2022-06-02 | Boor Kathryn Jean Director | Grant or award | +4,908 | 4,908 | ||
| 2022-06-02 | Boor Kathryn Jean Director | Grant or award · Stock Option (right to buy) | +8,329 | 8,329 |
Page 17 of 22 · 424 trades